NO974694L - Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus - Google Patents

Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus

Info

Publication number
NO974694L
NO974694L NO974694A NO974694A NO974694L NO 974694 L NO974694 L NO 974694L NO 974694 A NO974694 A NO 974694A NO 974694 A NO974694 A NO 974694A NO 974694 L NO974694 L NO 974694L
Authority
NO
Norway
Prior art keywords
phosphonoglycine derivatives
pharmaceutical preparation
preparation containing
phosphonoglycine
inhibit cancer
Prior art date
Application number
NO974694A
Other languages
English (en)
Other versions
NO974694D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO974694D0 publication Critical patent/NO974694D0/no
Publication of NO974694L publication Critical patent/NO974694L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Denne oppfinnelsen vedrører et farmasøytisk preparat som inhiberer veksten av cancere og tumorer i pattedyr, særlig i mennesker og varmblodsdyr. Preparatet er også effektivt mot viruser. Preparatet inneholder N-fosfonoglycin-derivater som er systemiske herbicider. Preparatet kan også inneholde N- fosfonoglycin-derivater i kombinasjon med kjemoterapeutiske midler for behandling av cancere og tumorer. Eventuelle potensatorer kan være innlemmet. N-fosfonoglycin-derivater sammen med en potensator kan anvendes for å behandle virale infeksjoner.
NO974694A 1995-04-12 1997-10-10 Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus NO974694L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/420,940 US5665713A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of viruses and cancers
US184095P 1995-08-03 1995-08-03
PCT/US1996/004954 WO1996032115A1 (en) 1995-04-12 1996-04-11 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers

Publications (2)

Publication Number Publication Date
NO974694D0 NO974694D0 (no) 1997-10-10
NO974694L true NO974694L (no) 1997-12-12

Family

ID=26669550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974694A NO974694L (no) 1995-04-12 1997-10-10 Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus

Country Status (18)

Country Link
US (3) US5665713A (no)
EP (1) EP0820291A1 (no)
JP (1) JPH11503458A (no)
KR (1) KR19980703830A (no)
CN (1) CN1181014A (no)
AR (1) AR003120A1 (no)
AU (1) AU714057B2 (no)
BR (1) BR9604951A (no)
CA (1) CA2217951A1 (no)
CZ (1) CZ323897A3 (no)
IL (1) IL117873A (no)
NO (1) NO974694L (no)
NZ (1) NZ305783A (no)
PL (1) PL322734A1 (no)
SK (1) SK138297A3 (no)
TR (1) TR199701148T1 (no)
TW (1) TW457088B (no)
WO (1) WO1996032115A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
DE19622355A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
AU747407B2 (en) * 1998-04-14 2002-05-16 Bioagency Ag Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7060643B2 (en) * 2000-12-28 2006-06-13 Showa Denko Kabushiki Kaisha Photo-functional powder and applications thereof
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
US20040006043A1 (en) * 2002-07-02 2004-01-08 Ramot University Authority For Applied Research & Industrial Development Ltd. Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
US7151092B2 (en) * 2002-10-31 2006-12-19 Metabasis Therapeutics, Inc. Cytarabine monophosphate prodrugs
EP2034828A4 (en) * 2006-05-19 2011-04-06 Univ Illinois PHOSPHOROUS COMPOUNDS CONTAINING TRIPHENYLMETHYLPHOSPHONATE ESTERS FOR THE TREATMENT OF MELANOMA AND OTHER CANCERS
WO2014025765A2 (en) * 2012-08-06 2014-02-13 University Of Miami Systems and methods for adaptive neural decoding
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3779758A (en) * 1969-03-25 1973-12-18 Photocircuits Corp Photosensitive process for producing printed circuits employing electroless deposition
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
US4634693A (en) * 1983-07-28 1987-01-06 Cardarelli Nathan F Tin steroids and their uses
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US4994591A (en) * 1989-06-02 1991-02-19 The Research Foundation Of State University Of Ny Platinum complexes derived from b-silyamines
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers

Also Published As

Publication number Publication date
IL117873A0 (en) 1996-08-04
NZ305783A (en) 2001-06-29
CN1181014A (zh) 1998-05-06
BR9604951A (pt) 1998-06-09
KR19980703830A (ko) 1998-12-05
CZ323897A3 (cs) 1998-03-18
SK138297A3 (en) 1998-05-06
WO1996032115A1 (en) 1996-10-17
TW457088B (en) 2001-10-01
AU5389696A (en) 1996-10-30
PL322734A1 (en) 1998-02-16
CA2217951A1 (en) 1996-10-17
US5665713A (en) 1997-09-09
US6090796A (en) 2000-07-18
JPH11503458A (ja) 1999-03-26
AR003120A1 (es) 1998-07-08
IL117873A (en) 2001-05-20
NO974694D0 (no) 1997-10-10
EP0820291A1 (en) 1998-01-28
TR199701148T1 (xx) 1998-02-21
AU714057B2 (en) 1999-12-16
US5854231A (en) 1998-12-29

Similar Documents

Publication Publication Date Title
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
NO974696L (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
ATE397621T1 (de) Hemmer der interaktion zwischen p53 und mdm2
TR199903053T2 (xx) Benzimidazol t�revleri.
HUP0100285A2 (hu) Protein kináz C inhibitorok alkalmazása daganatellenes szerek és sugárterápia klinikai hatékonyságának javítására szolgáló gyógyászati készítmények előállítására
NO954878L (no) Pyrrolderivater
NO975662L (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
NO980419L (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
WO1997005870A3 (en) Use of griseofulvin for inhibiting the growth of cancers
AR002987A1 (es) Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ATE236651T1 (de) Materialen und verfahren im zusammenhang mit der inhibierung der wechselwirkung der p53 und mdm2
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
CA2363973A1 (en) Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
HUP9700661A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása rák megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
BR0214564A (pt) Processos de tratamento de câncer utilizando um inibidor da fpt e agentes antineoplásicos
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
MX9300927A (es) Compuestos terapeuticos de triazina y su empleo.
MX9707810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimiento de virus y canceres.
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application